ForMyGluco
BlogGlossary← Home

Low blood sugar

What is glucagon, and when is it needed?

· 3 min

Two hands reaching toward each other on a plain white background; one open palm from below, the other extending a finger from above, no face in view.

Glucagon is the hormone the pancreas releases, and it does the opposite of insulin: it prods the liver’s store, which sends glucose into the blood. The drug form is for severe lows, the moments a person can’t recover alone. The main point: not the patient but someone nearby gives it.

The body has its own hormone against a low: glucagon. When blood sugar starts falling, the pancreas’s alpha cells release it; the hormone reaches the liver and turns the glycogen stored there into glucose. The liver doesn’t stop at that; it also builds new glucose from scratch. If insulin settles sugar into cells, glucagon takes it out of the store into circulation.

As a drug, glucagon repeats the body’s own job from outside. The case for it is narrow and clear: the person can’t be woken, answer questions, or swallow. Sugar in the mouth does nothing then; with the swallowing reflex off, it risks going down the windpipe. Glucagon needs no swallowing: it is absorbed not from the stomach but from muscle, under the skin, or the nose’s thin inner membrane.

QuestionCarbohydrate by mouthGlucagon
Who it suitsAwake, able to swallowCan’t swallow or be woken
Who gives itThe person themselvesSomeone else nearby
Where sugar comes fromFrom outside, by digestionThe liver’s own store
AfterwardAnother checkMedical help; carbohydrate once recovered

Two forms are common today. One goes in by needle. Powder and liquid used to sit apart in the box, and whoever gave it had to mix them; in a rush that step often failed. Ready-made pens and prefilled syringes removed that mixing step entirely. The other is a powder puffed into the nose; no breathing in needed, it crosses the nasal membrane on its own. The ADA’s standards of care put ready-made forms first, for ease of use.

The real matter: who will know. A severe low already means this: the person can’t recover alone, another hand is needed. So the ADA says glucagon should be prescribed for everyone on insulin or at high risk of lows, with those nearby taught the box’s place and use. Household, roommate, deskmate at work, staff at school, whoever sits beside you on a trip. A box in the bag nobody knows may as well not be there.

Glucagon’s first limit is the store itself. When liver glycogen runs low the effect weakens; long fasts, alcohol, and liver disease bring that on. So what shows the store fell short? Expected, within fifteen minutes of giving it: the eyes opening, the voice back, the gaze gathering. If that isn’t happening, glucagon hasn’t closed the picture; sources describe this as the moment to ask for medical help without delay.

The second limit is time. Blood sugar rises for a stretch, then starts falling again. Sweating, shaking, and fogginess coming back after recovery is the sign. For this, sources speak of returning to carbohydrate once the person can swallow. Nausea and vomiting are a common side effect; training materials therefore describe laying the person on their side.

Can someone give glucagon to themselves?
In a mild low, no need; in a severe low the person already can’t act alone. That is the definition. So the real matter is those nearby knowing the box.
Is there a needle-free form?
Yes, the powder puffed into the nose. The powder is absorbed from the moist membrane inside the nose, no breathing in needed. Sources explain this form this way: an untrained person gives it more easily.
Does glucagon work in every low?
Its effect depends on the liver’s store. In a long fast and after alcohol the store shrinks, the response stays weak. Nothing measures this; the person is the indicator. If they don’t wake, no response came and the job isn’t finished with glucagon.

Sources

  1. American Diabetes Association Professional Practice Committee. 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Supplement_1):S132–S149. doi:10.2337/dc26-S006
  2. Morris CH, Baker J. Glucagon. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. (Last updated: 6 February 2025.)
  3. Rix I, Nexøe-Larsen C, Bergmann NC, Lund A, Knop FK. Glucagon Physiology. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2019.
  4. La Sala L, Pontiroli AE. New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions. International Journal of Molecular Sciences. 2021;22(19):10643. doi:10.3390/ijms221910643
  5. Türkiye Endokrinoloji ve Metabolizma Derneği (TEMD). Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu-2026. 17. Baskı. TEMD; 2026. ISBN 978-625-99759-8-6

This piece is for information only; it is not a diagnosis, treatment or dosing recommendation. Always make decisions about your treatment together with your doctor.

Start keeping your own record

ForMyGluco keeps your readings, medications and appointments in one place, and prepares a doctor-ready PDF in a single tap.

View on the App Store →

All of the blog